Lantheus doses first patient in SPARROW Phase 2/3 prostate cancer imaging trial
The registrational study of LNTH-2401 is designed to generate data for a future diagnostic performance readout.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.